Şahsine Tolunay

1.2k total citations
77 papers, 870 citations indexed

About

Şahsine Tolunay is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Şahsine Tolunay has authored 77 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Oncology and 22 papers in Cancer Research. Recurrent topics in Şahsine Tolunay's work include Glioma Diagnosis and Treatment (13 papers), Breast Lesions and Carcinomas (13 papers) and MicroRNA in disease regulation (10 papers). Şahsine Tolunay is often cited by papers focused on Glioma Diagnosis and Treatment (13 papers), Breast Lesions and Carcinomas (13 papers) and MicroRNA in disease regulation (10 papers). Şahsine Tolunay collaborates with scholars based in Türkiye, United States and Russia. Şahsine Tolunay's co-authors include Ahmet Bekâr, Berrin Tunca, Ünal Egelí, Gülşah Çeçener, Türkkan Evrensel, Gülçin Tezcan, Hasan Kocaelı, Mevlüt Özgür Taşkapılıoğlu, İsmet Taşdelen and Erdem Çubukçu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Şahsine Tolunay

74 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Şahsine Tolunay Türkiye 18 310 293 226 146 128 77 870
Yvonne H. Datta United States 15 216 0.7× 139 0.5× 245 1.1× 110 0.8× 73 0.6× 24 982
Ryan M. Naylor United States 14 539 1.7× 190 0.6× 269 1.2× 140 1.0× 66 0.5× 47 1.1k
Wencai Li China 16 150 0.5× 110 0.4× 414 1.8× 171 1.2× 166 1.3× 72 897
Sung Mo Hur South Korea 17 203 0.7× 219 0.7× 223 1.0× 231 1.6× 115 0.9× 43 981
Liang Hong China 19 409 1.3× 268 0.9× 157 0.7× 214 1.5× 42 0.3× 61 979
Matthew J. Goldstein United States 14 212 0.7× 103 0.4× 318 1.4× 83 0.6× 75 0.6× 29 975
Smadar Avigad Israel 25 669 2.2× 235 0.8× 251 1.1× 349 2.4× 68 0.5× 67 1.4k
Zhiwei Zhou China 17 289 0.9× 99 0.3× 398 1.8× 288 2.0× 99 0.8× 53 997

Countries citing papers authored by Şahsine Tolunay

Since Specialization
Citations

This map shows the geographic impact of Şahsine Tolunay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şahsine Tolunay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şahsine Tolunay more than expected).

Fields of papers citing papers by Şahsine Tolunay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şahsine Tolunay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şahsine Tolunay. The network helps show where Şahsine Tolunay may publish in the future.

Co-authorship network of co-authors of Şahsine Tolunay

This figure shows the co-authorship network connecting the top 25 collaborators of Şahsine Tolunay. A scholar is included among the top collaborators of Şahsine Tolunay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şahsine Tolunay. Şahsine Tolunay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ertürk, Elif, et al.. (2024). Value of miR-31 and miR-150-3p as diagnostic and prognostic biomarkers for breast cancer. Molecular Biology Reports. 51(1). 1030–1030. 1 indexed citations
2.
Tolunay, Şahsine, et al.. (2024). Differential diagnosis of primary mesenchymal neoplasms of the breast. Clinical & Translational Oncology. 27(1). 223–232.
3.
Şenol, Kazım, et al.. (2024). Histopathological Features Predicting Neuroendocrine Morphology in Primary Breast Tumors: A Retrospective Analysis. SHILAP Revista de lepidopterología. 20(2). 110–116. 1 indexed citations
4.
5.
Tezcan, Gülçin, Seçil Ak Aksoy, Hasan Kocaelı, et al.. (2023). Concurrent presence of diabetes affects the GLUT3 programming of glucose metabolism in glioblastoma.. PubMed. 27(17). 8110–8118. 1 indexed citations
6.
Tolunay, Şahsine, et al.. (2023). Metastatic Neoplasms to the Breast. International Journal of Surgical Pathology. 32(5). 875–883. 1 indexed citations
7.
Aksoy, Seçil Ak, Mevlüt Özgür Taşkapılıoğlu, Pınar Eser Ocak, et al.. (2021). Long non-coding RNAs as a predictive markers of group 3 medulloblastomas. Neurological Research. 44(3). 232–241. 6 indexed citations
8.
Ak, Seçil, Gamze Güney Eskiler, Elif Ertürk, et al.. (2016). Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.. PubMed. 17(9). 4241–4246. 23 indexed citations
9.
Avcı, Nilüfer, et al.. (2015). Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.. PubMed. 20(1). 45–9. 15 indexed citations
10.
Tezcan, Gülçin, Berrin Tunca, Ahmet Bekâr, et al.. (2014). Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression.. PubMed. 4(5). 572–90. 27 indexed citations
11.
Ölmez, Ömer Fatih, Türkkan Evrensel, Erdem Çubukçu, et al.. (2013). Prognostic Significance of Human Epidermal Receptor (HER)-3 Immunohistochemical Expression in Patients with Metastatic Breast Cancer. Asian Pacific Journal of Cancer Prevention. 14(7). 4115–4119. 2 indexed citations
12.
Özmen, Ahmet, et al.. (2013). A Case of Spinal Intradural Extramedullary Hydatid Cyst Mimicking a Spinal Tumor. Turkiye Klinikleri Journal of Medical Sciences. 33(2). 572–575. 2 indexed citations
13.
Taşdelen, İsmet, et al.. (2013). A comparison of Ki 67 proliferative index in primary tumor and axillary metastatic lymph nodes with length of survival in patients with breast cancer. Bratislavské lekárske listy/Bratislava medical journal. 114(11). 645–649. 7 indexed citations
14.
Tolunay, Şahsine, et al.. (2012). The relationship between the stromal mast cell number, microvessel density, c-erbb-2 staining and survival and prognostic factors in colorectal carcinoma. Turkish Journal of Pathology. 28(2). 110–110. 12 indexed citations
15.
Tunca, Berrin, Ünal Egelí, Gülşah Çeçener, et al.. (2012). CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.. PubMed. 98(2). 243–51. 11 indexed citations
16.
Kanat, Özkan, Taner Korkmaz, Erdem Çubukçu, et al.. (2012). Primary small cell carcinoma of the breast: report of seven cases and review of the literature.. PubMed. 97(4). 473–8. 17 indexed citations
17.
Topal, Uğur, et al.. (2011). Malignant spiculated breast masses: Dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation. European Journal of Radiology. 81(2). 203–208. 8 indexed citations
18.
Tolunay, Şahsine, et al.. (2011). Histopathologic Characteristics of Sentinel Lymph Node Biopsy in Breast Carcinoma: Uludağ University Faculty of Medicine Experience. Turkiye Klinikleri Journal of Medical Sciences. 31(6). 1324–1329. 2 indexed citations
19.
Kütük, Özgür, Şehime Gülsün Temel, Şahsine Tolunay, & Hüveyda Başağa. (2010). Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL. European Journal of Cancer. 46(13). 2494–2505. 28 indexed citations
20.
Demiray, Mutlu, Ender Kurt, Türkkan Evrensel, et al.. (2005). Phase II Study of Gemcitabine Plus Paclitaxel in Metastatic Breast Cancer Patients with Prior Anthracycline Exposure. Cancer Investigation. 23(5). 386–391. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yvonne H. Datta Breakdown of academic impact, for papers by Ryan M. Naylor Breakdown of academic impact, for papers by Wencai Li Breakdown of academic impact, for papers by Sung Mo Hur Breakdown of academic impact, for papers by Liang Hong Breakdown of academic impact, for papers by Matthew J. Goldstein Breakdown of academic impact, for papers by Smadar Avigad Breakdown of academic impact, for papers by Zhiwei Zhou
Rankless by CCL
2026